Form 4: Cognex M&A Head Sells Shares After Option Exercises
Insider Transaction Report
Joerg Kuechen, Cognex's Head of Corporate M&A, reported multiple transactions involving the exercise of stock options and vesting of restricted stock units, followed by sales of common stock.
Summary
- Joerg Kuechen, Head of Corporate M&A, engaged in multiple transactions on February 20 and 21, 2026.
- Exercised non-qualified stock options to acquire 11,029 shares at $33.04, 12,500 shares at $38.39, and 35,642 shares at $39.44.
- Vested 5,325 and 6,355 restricted stock units (RSUs) at an exercise price of $0.0.
- Sold a total of 59,171 common shares at prices ranging from $55.9801 to $56.2401.
- Disposed of 2,575 shares and 3,073 shares to cover tax withholding obligations related to RSU vesting, both at $56.03.
- Following these transactions, direct beneficial ownership of common stock is 6,032 shares.
- Retains significant derivative holdings including various non-qualified stock options and restricted stock units.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The transactions are largely routine for executive compensation, involving option exercises and RSU vesting followed by sales to cover costs and taxes, rather than a discretionary sale indicating a change in sentiment.
Positives
- Vesting of Restricted Stock Units (RSUs) at $0.0 exercise price indicates a compensation structure aligning management interests with shareholder value.
- Exercise of stock options at lower prices than market value demonstrates the value of long-term incentive plans.
Negatives
- Significant sales of common stock (59,171 shares) by a key executive, even if related to option exercises and RSU vesting, could be perceived negatively by some investors.
- The sales occurred at prices between $55.9801 and $56.2401, indicating the executive capitalized on the current market price.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- Joerg Kuechen, Head of Corporate M&A, engaged in transactions involving Cognex Corporation common stock, including option exercises, RSU vesting, and subsequent sales.
Stakeholder Impact
- Shareholders: The sale of shares by an executive could be viewed with slight caution, though it's largely offset by the routine nature of option exercises and RSU vesting. It does not signal a strong vote of confidence or lack thereof.
- Employees: No direct impact.
- Customers: No direct impact.
- Suppliers: No direct impact.
- Creditors: No direct impact.
Key Dates
| Date | Description |
|---|---|
| 02/21/2017 | Grant date for options vesting in four equal annual installments. |
| 02/21/2018 | First vesting anniversary for options granted on 02/21/2017. |
| 02/20/2019 | Date exercisable for Non-Qualified Stock Option with exercise price $56.44 and expiration 02/20/2028. |
| 02/19/2020 | Date exercisable for Non-Qualified Stock Option with exercise price $51.49 and expiration 02/19/2029. |
| 02/18/2021 | Date exercisable for Non-Qualified Stock Option with exercise price $50.94 and expiration 02/18/2030. |
| 02/16/2022 | Date exercisable for Non-Qualified Stock Option with exercise price $90.5 and expiration 02/16/2031. |
| 02/22/2023 | Date exercisable for Non-Qualified Stock Option with exercise price $64.43 and expiration 02/22/2032. |
| 02/21/2023 | Grant date for restricted stock units vesting approximately 20%, 30%, and 50% on the first, second, and third anniversaries. |
| 02/20/2024 | Grant date for options vesting in five approximately equal annual installments. Also, grant date for restricted stock units vesting approximately 20%, 30%, and 50% on the first, second, and third anniversaries. |
| 02/21/2024 | First vesting anniversary for restricted stock units granted on 02/21/2023. Also, date exercisable for Non-Qualified Stock Option with exercise price $47.21 and expiration 02/21/2033. |
| 02/18/2025 | Grant date for options vesting in five approximately equal annual installments. |
| 02/20/2025 | First vesting anniversary for options granted on 02/20/2024. Also, first vesting anniversary for restricted stock units granted on 02/20/2024. |
| 02/20/2026 | Transaction date for multiple option exercises, RSU vesting, and common stock sales. Also, vesting date for restricted stock units. |
| 02/21/2026 | Transaction date for RSU vesting and common stock sales. Also, vesting date for restricted stock units. |
| 02/24/2026 | Signature date of the reporting person. |
| 08/04/2026 | Date exercisable for Non-Qualified Stock Option with exercise price $47.95 and expiration 08/04/2032. |
| 02/18/2026 | Date exercisable for Restricted Stock Unit with $0.0 price and expiration 02/18/2028. |
| 02/20/2027 | Expiration date for Restricted Stock Unit with $0.0 price and date exercisable 02/20/2025. |
| 02/21/2027 | Expiration date for Non-Qualified Stock Option with exercise price $38.39 and date exercisable 02/21/2018. |
| 02/17/2028 | Date exercisable and expiration date for Restricted Stock Unit with $0.0 price. |
| 02/18/2028 | Expiration date for Restricted Stock Unit with $0.0 price and date exercisable 02/18/2026. |
| 02/20/2028 | Expiration date for Non-Qualified Stock Option with exercise price $56.44 and date exercisable 02/20/2019. |
| 02/19/2029 | Expiration date for Non-Qualified Stock Option with exercise price $51.49 and date exercisable 02/19/2020. |
| 02/18/2030 | Expiration date for Non-Qualified Stock Option with exercise price $50.94 and date exercisable 02/18/2021. |
| 02/16/2031 | Expiration date for Non-Qualified Stock Option with exercise price $90.5 and date exercisable 02/16/2022. |
| 02/22/2032 | Expiration date for Non-Qualified Stock Option with exercise price $64.43 and date exercisable 02/22/2023. |
| 08/04/2032 | Expiration date for Non-Qualified Stock Option with exercise price $47.95 and date exercisable 08/04/2026. |
| 02/21/2033 | Expiration date for Non-Qualified Stock Option with exercise price $47.21 and date exercisable 02/21/2024. |
| 02/20/2034 | Expiration date for Non-Qualified Stock Option with exercise price $39.44 and date exercisable 02/20/2025. |
| 02/18/2035 | Expiration date for Non-Qualified Stock Option with exercise price $33.04 and date exercisable 02/18/2026. |
Recommendation
holdThe reported transactions are routine insider activity related to executive compensation, specifically option exercises and RSU vesting followed by sales to cover taxes and exercise costs. They do not indicate a significant change in the company's fundamentals or future prospects that would warrant a change in investment recommendation. Investors should continue to hold based on broader company performance and market conditions.
Keywords
Cognex, CGNX, Insider Trading, Form 4, Stock Options, Restricted Stock Units, Executive Compensation, Share Sale, Joerg Kuechen
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.